---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-023458"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2023-07-05T23:59:59+00:00"
generated_at: "2026-06-13T12:38:06.503150+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nasdaq confirms Bone Biologics compliance with minimum bid price; one-year panel monitor imposed

## Summary
- Received letter from Nasdaq Hearings Advisor on June 28, 2023 confirming compliance with Listing Rule 5550(a)(2) for minimum bid price.
- Company subject to Panel Monitor through June 27, 2024; any future non-compliance triggers immediate delisting process with no cure period.
- During monitoring, failure to meet any continued listing requirement forfeits standard compliance plan and cure periods, risking delisting.
- Company's common stock (BBLG) and warrants (BBLGW) trade on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001493152-23-023458
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2023-07-05T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315223023458/0001493152-23-023458-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315223023458/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-023458
- JSON: https://secwatch.observer/filing/0001493152-23-023458.json
- Plain text: https://secwatch.observer/filing/0001493152-23-023458.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.